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What is already known about this subject 
	There is rising prevalence of overweight and obesity among groups with lower socioeconomic status (SES).
	Obesity-related diseases are not equally distributed across different socioeconomic groups.
	Compared to normal-weight individuals, individuals with overweight and obesity have higher direct and indirect costs over lifetime. 

What this study adds 
	This study substantially extends previous simulation-based cost-of-illness studies by including socioeconomic disparities measured by a multi-dimensional aggregated index, thereby underscoring the influence of SES on the magnitude and direction of expected lifetime costs of overweight and obesity.
	This study brings attention to opposite socioeconomic gradients in lifetime costs due to obesity compared to overweight, thus demonstrating the need to prioritise resources.
	DC-Obesity may form an economic foundation for urgently needed obesity prevention and treatment programmes targeted at vulnerable SES groups and their specific needs. 





Abstract
Objective. To quantify the magnitude of lifetime costs of overweight and obesity by socioeconomic status (SES). 
Methods. DC-Obesity is a new model that uses time-to-event simulation and the Markov modelling approach to compare lifetime excess costs of overweight and obesity among individuals with low, middle and high SES. SES was measured by a multi-dimensional aggregated index based on level of education, occupational class and income using longitudinal data of the German Socio-economic Panel (SOEP). We applied random effects meta-analysis to combine estimates of (in-)direct costs of overweight and obesity.
Results. DC-Obesity brings attention to opposite socioeconomic gradients in lifetime costs due to obesity compared to overweight. Compared to individuals with obesity and high SES, individuals with obesity and low SES had two times higher lifetime excess costs (€8,526). In contrast, these costs were 20% higher in groups with overweight and high SES than in groups with overweight and low SES (€2,711).
Conclusions. Our results indicate that SES may play a pivotal role in designing cost-effective and sustainable interventions to prevent and treat overweight and obesity. DC-Obesity may help public policy planners to make informed decisions about obesity programmes targeted at vulnerable SES groups.



 

Introduction
The health and economic consequences of overweight and obesity are undeniable. However, their distribution in the population is unequal, which is creating increasing concerns  ADDIN EN.CITE (, ). Indeed, a growing body of literature  ADDIN EN.CITE (, ) () has confirmed a higher and often persistent prevalence of overweight and obesity among groups with lower socioeconomic status (SES). In Germany, for example, women with low SES are more likely to gain weight and have thus a three times higher risk of becoming obese than women with high SES  ADDIN EN.CITE () (). Additionally, it has been shown that individuals with low SES have a higher probability of utilizing general medical services due to obesity-related disorders. This may result in higher health care costs compared to individuals with high SES, even after adjusting for potential confounders  ADDIN EN.CITE (). 
Despite the above findings most (inter-)national cost-of-illness (COI) studies do not quantify how these costs change across various SES groups  ADDIN EN.CITE (, , ). In the European context, only one German study () has attempted to quantify the health care costs of overweight and obesity by SES. However, since this study is based on a cross-sectional health survey in the Augsburg region of Germany, the generalisability of estimations of costs is limited. Moreover, this study does not consider the indirect costs and lifetime consequences of overweight and obesity. While indirect costs are productivity losses due to early mortality or morbidity (e.g. due to early retirement), direct costs represent the monetary value of resources used to manage obesity-related diseases (e.g. medical expenditures).
Since we are not aware of any COI study that estimates differential indirect and indirect lifetime costs across socioeconomic groups, our paper aims to analyse the cost burden of overweight and obesity by SES.


 Methods
In this subsection, we discuss the modelling approach, design and model parameters of DC-Obesity.

Modelling approach and design of DC-Obesity
DC-Obesity is a simulation-based model to estimate lifetime costs of overweight and obesity by SES. Specifically, we developed a new modelling approach by combining time-to-event simulation and Markov modelling. While time-to-event simulation was used to estimate model parameters (e.g. probability of changing BMI), Markov modelling, a common approach in health economics, was applied to evaluate long-term risk of morbidity and mortality and associated costs in a cohort  ADDIN EN.CITE (, ). DC-Obesity was developed in Microsoft Excel 2010 (Microsoft Corporation, Redmond, WA, USA) with Visual Basic for Application (VBA). Data mangement and time-to-event simulations were conducted using Stata version 14.1 (StataCorp. 2015, College Station, TX: StataCorp LP). 
DC-Obesity consists of three base cohorts: individuals with low, middle and high SES (see Figure 1). For each SES group, we assumed that individuals enter at age 18 and then move, depending on their BMI status at this age, through the normal weight, overweight or obese pathway. BMI states are defined according to WHO standards as: 1) normal weight (BMI < 25kg/m2); 2) overweight (BMI ≥ 25kg/m2 to BMI < 30kg/m2); and 3) obese (BMI ≥ 30kg/m2). With 3.66% (12.82%) of adults with obesity (overweight), the initial distribution of the starting cohort of individuals with low SES was in line with the BMI distribution at age 18 in Germany in 2016. The same holds for the initial distribution of the starting cohorts with middle SES and high SES.
The chance of moving from one BMI state to another (e.g. from normal weight to overweight) depends on SES-specific transition probabilities measuring the proportion of individuals within an SES group who change their BMI status in a given time period (here: one year). The obesity literature suggests that these probabilities depend on the history of BMI (i.e. whether or not an individual was previously overweight or obese). However, Markov models are memoryless, i.e. individuals within a health state (such as normal weight) cannot be distinguished according to their history of BMI. We incorporated this risk information in DC-Obesity by considering individuals who were always normal weight and individuals who were overweight and then become normal weight (see overweight pathway in Figure 1). Similarly, we included the BMI state “overweight (after obese)” (see obese pathway). 
We simulated each cohort (low, middle and high SES) until the age of 80 to estimate direct and indirect costs of overweight and obesity depending on SES. We excluded ages beyond 80 for two major reasons. Firstly, since lean body mass (LBM) significantly decreases in older age, a higher BMI is thought to protect against bone density loss and osteoporosis, which may result in lower health care costs  ADDIN EN.CITE (, ). Secondly, the small sample size beyond age 80 would reduce the generalisability of our results. Lifetime excess costs of overweight and obesity were calculated for each SES group by the difference in lifetime costs between individuals who were always normal weight and individuals who were always overweight/obese.

Model Parameters
DC-Obesity is based on parameters from longitudinal data sets such as the German Socio-Economic Panel (SOEP) and the literature, as described below (Appendix 1 for all parameters and data sources). The SOEP (SOEPlong release v29; German Institute for Economic Research [DIW], Berlin) is the largest and longest running longitudinal study of more than 20,000 German adults aged 18-100 years and has individual-level data on self-reported BMI every two years over a 10-year period (). 

Socioeconomic status 
Following Lampert et al. (), we calculated a multi-dimensional aggregated index to measure SES by using data from the SOEP. We used three dimensions: education, occupational status and net equivalent income. Education was measured as the highest level successfully completed. Using the international classification Comparative Analyses of Social Mobility in Industrial Nations (CASMIN) (), we organised the original data into six classes (none, primary, secondary, tertiary, technical school, not specified). Occupational status was classified according to the International Socio-Economic Index of Occupational Status (ISEI) (). We classified the original data into this scheme, which was then reorganised into six classes (farmers, technicians, self-employed workers, employees, officials, graduates). Net income was measured as the sum of all income components of all household members and adjusted for household size (equivalised disposable income). Finally, we used this SES index to differentiate among low (<20%), middle (20%-80%) and high (>80%) SES (). 

SES-specific state transition probabilities between BMI states 
To estimate SES-specific state transition probabilities, we used data from the SOEP () (see Appendix 2 for detailed statistical analysis). The probability of moving between BMI states (e.g. from normal weight to overweight) not only depends on individual characteristics like age and sex but also on how long an individual has stayed in a specific BMI state (e.g. slow or rapid weight change in a given time period). To evaluate this, we used the time to BMI change as the primary outcome using flexible parametric survival models. These models are more appropriate than conventional parametric (e.g. Weibull) models because they allow estimation of BMI trajectories that change over time (e.g. a normal-weight individual can become overweight and then can become normal weight again) () (). 

Risk of mortality
All cause-mortality risks were based on age- and sex-specific mortality rates reported in the most recent German life table (2012) (). Mortality among the overweight and obese was calculated using the European Prospective Investigation into Cancer and Nutrition (EPIC),  ADDIN EN.CITE () which is a large European cohort study based on 10 European countries (Table 1). In the absence of published longitudinal studies reporting SES-specific mortality risks based on three socioeconomic dimensions, i.e. education, occupational status and net equivalent income, we used data from the most recent study that estimated SES-specific mortality risk based on the SOEP (). 

Costs associated with overweight and obesity 
In this study we considered direct and indirect costs based on a systematic literature review in our companion papers (, ). This literature review focused on German COI studies; most of them were restricted to obesity-related in- and outpatient costs (direct costs) and costs from sick leave (indirect costs). Only three out of the seven studies  ADDIN EN.CITE (, , ) were eligible and included in the meta-analysis (since they presented standard error or confidence intervals and applied a similar methodological approach). Following Higgins et al. () and Bland and Altman (), we applied a random effects meta-analysis to estimate the mean of direct and indirect costs. All costs were indexed to year 2016 euros (€) (Appendix 1, Table A1).

Sensitivity and scenario analyses
Probabilistic sensitivity analyses (PSA; Monte Carlo simulations) were used to test the robustness of our results. More specifically, we randomly sampled parameter values from statistical distributions defined by standard error or confidence interval estimates in the literature. We ran 10,000 simulations for the PSA (). Common statistical distributions were used for relative risks (log normal distribution) and costs (gamma distribution) (). A uniform distribution was used when only the parameter range was available without standard errors. The 95% confidence intervals based on the PSA are reported in the Results section ().
To assess the magnitude of the intervention effect necessary for significant cost savings, we conducted two scenario analyses: reduction of BMI at baseline by 1% and by 14% (which is potentially achievable based on a national evaluation study of outpatient and inpatient care in Germany, EvAKuJ study ()).

Results
We used flexible parametric survival models to estimate SES-specific transition probabilities based on longitudinal data from Germany and then projected BMI trajectories and associated costs over lifetime using a cohort modelling approach.

Lifetime excess costs attributable to overweight and obesity by SES category
Table 2 shows the excess lifetime costs of overweight and obesity per person and SES category. We calculated excess lifetime costs as the difference between expected lifetime costs for individuals with overweight/obesity and normal-weight individuals. We found that obesity is the top contributor to lifetime excess costs with a declining socioeconomic gradient. More specifically, excess lifetime costs (discounted at 3%) were €11,273 (95% CI 2,985-14,226) for individuals with low SES, €10,596 (95% CI 4,464-14,889) for individuals with middle SES and €8,080 (95% CI 7,933-14,201) for individuals with high SES. This variation in costs is likely due to the low prevalence of obesity in individuals with high SES at each age (10.91% in high SES group versus 20.20% in low SES group) and lower transition probabilities of moving to a higher BMI category (e.g. from normal weight to overweight). Figure 2a shows the probability of moving to a higher BMI category in the next 10 years stratified by three age groups, i.e. young adulthood (<40 years), adulthood (40-64 years) and maturity (>65 years). Indeed, compared to individuals with low SES, individuals with high SES were less likely to become overweight or obese across all age groups. Particularly in middle and older age groups, we observed a significant inverse SES-related relationship between low and high SES, which indicates that SES plays a much bigger role later in life in determining weight gain. 
Figure 3 presents the cumulative excess costs of overweight and obesity by SES category. As the figure shows, there are three striking patterns in magnitude and direction of cumulative excess costs. While individuals with overweight and high SES had higher cumulative excess costs than individuals with middle or low SES, individuals with obesity and high SES had significantly lower cumulative excess costs than individuals with middle or low SES. Moreover, compared to individuals with overweight, individuals with obesity showed a larger magnitude of cost difference between high SES and low SES. Finally, we observed a more moderate increase in costs due to overweight (compared to obesity), which is probably because young adults with overweight are more likely to lose weight than young adults who have been obese since childhood and find it thus harder to lose weight (Figure 2b). 


Expected cost savings due to reductions in overweight and obesity
Given the high excess lifetime costs of overweight and obesity, it is important to calculate to what extent changing the current obesity trend would affect the magnitude of these costs. Table 2 presents the expected reduction in excess costs due to a change in the prevalence of overweight and obesity in the cohorts analysed in this paper. We found a slight change (0.7%) in expected lifetime excess costs across all SES groups if the prevalence of overweight and obesity were reduced by 1% at baseline. Moreover, even if the prevalence of overweight and obesity were reduced by 14% at baseline, the expected reduction in lifetime costs would still be only 1.1%. However, we also found that these small changes (1.1% or less) in expected lifetime excess costs per person would result in substantial cost savings on the population level. Specifically, we estimated cost savings of approximately €0.2 billion for the current prevalent population of Germany; 40% of these cost savings were incurred in the low SES group.

Discussion
DC-Obesity may serve as an economic toolkit to inform and guide policy makers responsible for investment decisions in obesity programmes. For example, DC-Obesity draws attention to opposite socioeconomic gradients in lifetime costs due to obesity compared to overweight, thereby demonstrating the need to prioritise resources. Compared to individuals with obesity and high SES, individuals with obesity and low SES had two times higher lifetime excess costs (€8,526). In contrast, individuals with overweight and high SES have 20% higher lifetime excess costs than individuals with overweight and low SES  (€2,711). There are two main reasons for these opposite socioeconomic gradients. Firstly, the relatively high lifetime excess costs due to obesity in young adulthood likely result from the persistence of obesity in adolescence or even childhood. Indeed, the most recent systematic literature review  ADDIN EN.CITE () provides strong evidence that adolescents with obesity are five times more likely to remain obese over lifetime than those who become obese later in life. As shown in our analysis, particularly young adults with obesity and low SES are less likely to lose weight than older individuals in the same SES group who became obese later in life. Secondly, individuals with overweight and high SES have slightly higher expected lifetime excess costs than individuals with overweight and low SES. This is because they tend to develop cost-intensive, overweight-associated co-morbidities as their lifestyle changes with increasing SES and they are thus more likely to visit specialists rather than general practitioners  ADDIN EN.CITE (). 
While other incidence-based COI studies  ADDIN EN.CITE (, , ) have generally only estimated substantial lifetime costs of overweight and obesity, our study considers differential lifetime costs by SES in terms of a multi-dimensional aggregated index, which includes income, education and occupation. There is, however, one prevalence-based German COI study () that quantifies direct excess costs of overweight and obesity by SES. In contrast to our results, however, direct excess costs of obesity were higher in individuals with high SES compared to those with low SES. Yet their estimates are not comparable with ours since Lengerke et al. () applied a different approach, which was based on a cross-sectional analysis using generalised linear models to estimate annual excess costs of overweight and obesity by SES. More importantly, their analysis is restricted to low and high SES measured by an SES index () which substantially differs from the SES index applied in DC-Obesity.
Our study has a number of strengths. To our knowledge, DC-Obesity is the first simulation-based COI study for Germany which quantifies lifetime excess costs of overweight and obesity by SES. It demonstrates that expected lifetime excess costs of overweight and obesity are particularly high among individuals with low SES (see Table 2), which identifies them as an important target group for prevention and treatment interventions. Furthermore, it identifies a second important target group, which comprises individuals with overweight and high SES. More significantly, DC-Obesity provides a valuable basis for assessing the cost-effectiveness of interventions to prevent overweight and obesity in various SES and age groups. This, in turn, allows resources to be effectively allocated since interventions for prevention, particularly in young adulthood, could reduce the growing socioeconomic discrepancies in the aging population of Germany. Another strength of DC-Obesity is its innovative approach, which combines time-to-event simulation with dynamic incidence-based modelling. It is thus possible to estimate more accurately the probabilities of changing BMI and to establish cost trajectories over lifetime. Indeed, the time-to-event simulation took account of the influence of SES and other important risk factors on non-monotonic BMI trajectories over lifetime by using individual-level data from the largest longitudinal panel in Germany. In addition, we incorporated competing risks. This permits a more precise prediction of temporal trends in various SES groups, where hazard rates of changing BMI may differ with age. Finally, DC-Obesity takes account of the history of BMI over lifetime. For instance, we distinguish between individuals who were always normal weight and those who were normal weight after being overweight, enabling a more accurate risk estimation of morbidity and mortality attributable to overweight and obesity. 
Our study also has some limitations, which mainly arise from data restrictions. Firstly, DC-Obesity captures indirect costs due to work absences but considers neither further categories of indirect costs (e.g. opportunity costs of (in-)formal care ()) nor costs in non-health sectors like transportation (e.g. increased environmental costs due to larger vehicles for heavier individuals ()). However, if good-quality data on estimates of these costs related to SES groups are available, DC-Obesity does have the flexibility to estimate the additional burdens associated with these non-health costs. Secondly, our meta-analysis combined cost estimates from different age groups and settings in Germany. This contributes not only to the variability of expected lifetime excess costs related to overweight and obesity but also to a limited generalisibility of the findings of DC-Obesity since the health care system of Germany substantially differs from that of other European countries (e.g. United Kingdom). Finally, DC-Obesity does not model socioeconomic mobility (i.e. change in SES group) and its association with changes in BMI. In our sample, the majority of individuals (85%) remained in the same SES group. Moreover, we did not find any evidence of a robust statistically significant relationship between change in SES and BMI category (data not shown). We also acknowledge that the relationship between obesity and cost is associational in nature and may not necessarily imply causality due to unobserved factors that may influence the level of healthcare utilization. This is a limitation of our study which is similar to other obesity models  ADDIN EN.CITE (, , ). For instance, individuals with low SES (who are more likely to become obese, as shown by DC-Obesity), may also have lower access to health care (particularly, to those programmes that not covered by statutory health insurance). By taking account of this, our estimations of lifetime costs would be higher (). Similarly, weight loss is influenced by numerous personal, often unobservable, characteristics (e.g. health preferences), which led to biased estimations of cost-savings in DC-Obesity. The application of statistical methods taking account of such biases is an invaluable first step to estimate causal effects in obesity research. 
In summary, by using DC-Obesity we showed that SES may play a pivotal role in designing interventions to prevent and treat overweight and obesity. Indeed, a consideration of SES is essential to make informed decisions on allocating scarce public policy resources effectively. Moreover, since obesity is a complex disease and there is only limited evidence about the causal pathway between SES and obesity (e.g. obesity as a result of low SES or vice versa), the successful implementation of obesity programmes requires the strong commitment of multiple sectors, such as health, finance, education and family planning. Indeed, for decision makers in many of these sectors, DC-Obesity may provide the health economic model they need for targeted and cost-effective obesity interventions.
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Figure Legend:
Figure 1: 	Design of DC-Obesity – Modelling the normal weight, overweight and obese pathway depending on SES
Figure 2a: 	Probability of moving to a higher BMI-category in the next 10 years, by age and SES group
Figure 2b: 	Probability of moving to a lower BMI-category in the next 10 years, by age and SES group
Figure 3: 	Cumulative excess cost of overweight and obesity, stratified by SES category (2016, €)
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